Trials / Terminated
TerminatedNCT01081028
Connect® MM- The Multiple Myeloma Disease Registry
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,011 (actual)
- Sponsor
- Celgene · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the Connect® MM Registry is to explore the natural history and real world management of patients with newly diagnosed symptomatic multiple myeloma (MM) and provide unique insights into the management of MM and the impact of this hematologic disorder on patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | First-line therapy | As prescribed by treating physician |
| DRUG | Second-line Multiple Myeloma treatments | As prescribed by the treating physician |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2010-03-05
- Last updated
- 2026-04-13
Locations
253 sites across 2 countries: United States, Puerto Rico
Source: ClinicalTrials.gov record NCT01081028. Inclusion in this directory is not an endorsement.